Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Payables (2022 - 2025)

Historic Payables for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$2.5 million.

  • InflaRx's Payables fell 80578.48% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.5 million, marking a year-over-year decrease of 80578.48%. This contributed to the annual value of $12.3 million for FY2024, which is 6405.15% up from last year.
  • As of Q3 2025, InflaRx's Payables stood at -$2.5 million, which was down 80578.48% from -$1.9 million recorded in Q2 2025.
  • In the past 5 years, InflaRx's Payables registered a high of $12.2 million during Q4 2024, and its lowest value of -$4.7 million during Q1 2024.
  • For the 4-year period, InflaRx's Payables averaged around -$10105.2, with its median value being -$706115.1 (2022).
  • Per our database at Business Quant, InflaRx's Payables skyrocketed by 30543.13% in 2023 and then plummeted by 169026.2% in 2024.
  • Over the past 4 years, InflaRx's Payables (Quarter) stood at -$3.7 million in 2022, then surged by 305.43% to $7.5 million in 2023, then skyrocketed by 61.97% to $12.2 million in 2024, then tumbled by 120.8% to -$2.5 million in 2025.
  • Its Payables was -$2.5 million in Q3 2025, compared to -$1.9 million in Q2 2025 and -$3.2 million in Q1 2025.